CT1 Cardiothoracic Surgery, Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, UK.
Scott Med J. 2014 Feb;59(1):e6-8. doi: 10.1177/0036933013519027. Epub 2014 Jan 13.
Severe Factor XI (FXI) deficiency is defined when the activated partial thromboplastin time is prolonged and its activation is <1-15 UdL(-1) in plasma. It is inherited as an autosomal recessive trait but can be acquired. In severe deficiency the bleeding diathesis is normally injury related. This particularly occurs during surgical procedures and trauma involving tissues rich in fibrinolytic activators. Cardiopulmonary bypass induces transient abnormalities in haemostasis which can cause a postoperative bleeding diathesis. Once treated, it does not appear to be a contraindication to cardiac procedures. Conversely, acquired deficiencies are more insidious being incidentally diagnosed during routine laboratory investigations and might be triggered by an inhibitory agent. We present a case of an uncomplicated 12-month delayed diagnosis of Factor XI deficiency following coronary artery bypass grafting and sternal rewiring. The potential risks if undiagnosed and the uncharacteristic clinical history of our case are discussed.
严重的因子 XI(FXI)缺乏症的定义是,当活化部分凝血活酶时间延长,其在血浆中的激活度<1-15 UdL(-1)时。它作为常染色体隐性遗传特征遗传,但也可能是获得性的。在严重缺乏的情况下,出血倾向通常与损伤有关。这种情况尤其发生在涉及富含纤维蛋白溶解激活剂的组织的外科手术和创伤期间。体外循环会引起短暂的止血异常,从而导致术后出血倾向。一旦得到治疗,它似乎不是心脏手术的禁忌症。相反,获得性缺乏症更为隐匿,在常规实验室检查中偶然诊断出来,可能由抑制剂触发。我们报告了一例冠状动脉旁路移植术和胸骨再布线后 12 个月无症状的因子 XI 缺乏症延迟诊断的病例。讨论了未被诊断出的潜在风险以及我们病例的非典型临床病史。